Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up

被引:11
作者
de Rooij, Esther N. M. [1 ,2 ]
de Fijter, Johan W. [1 ]
Le Cessie, Saskia [2 ]
Hoorn, Ewout J. [3 ]
Jager, Kitty J. [4 ,5 ]
Chesnaye, Nicholas C. [4 ,5 ]
Evans, Marie [7 ,8 ]
Windahl, Karin [7 ,8 ]
Caskey, Fergus J. [9 ]
Torino, Claudia [10 ]
Szymczak, Maciej [11 ]
Drechsler, Christiane [12 ]
Wanner, Christoph [12 ]
Dekker, Friedo W. [2 ]
Hoogeveen, Ellen K. [1 ,6 ]
机构
[1] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
[3] Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands
[4] Univ Amsterdam, European Renal Assoc ERA Registry, Amsterdam UMC, Med Informat, Amsterdam, Netherlands
[5] Amsterdam Publ Hlth Res Inst, Qual Care, Amsterdam, Netherlands
[6] Jeroen Bosch Hosp, Dept Nephrol, Den Bosch, Netherlands
[7] Karolinska Inst, Dept Clin Intervent & Technol, Renal Unit, Stockholm, Sweden
[8] Karolinska Univ Hosp, Stockholm, Sweden
[9] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England
[10] CNR, Inst Clin Physiol, Reggio Di Calabria, Italy
[11] Wroclaw Med Univ, Dept Nephrol & Transplantat Med, Wroclaw, Poland
[12] Univ Hosp Wurzburg, Div Nephrol, Wurzburg, Germany
关键词
MORTALITY; DISEASE; HYPERKALEMIA; ASSOCIATION; OUTCOMES; SODIUM;
D O I
10.1053/j.ajkd.2023.03.008
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: Hypokalemia may accelerate kidney function decline. Both hypo- and hyperkalemia can cause sudden cardiac death. However, little is known about the relationship between serum potassium and death or the occurrence of kidney failure requiring replacement therapy (KRT). We investigated this relationship in older people with chronic kidney disease (CKD) stage 4-5. Study Design: Prospective observational cohort study. Setting & Participants: We followed 1,714 patients (>= 65 years old) from the European Quality (EQUAL) study for 8 years from their first estimated glomerular filtration rate (eGFR) < 20 mL/min/1.73 m(2) measurement. Exposure: Serum potassium was measured every 3 to 6 months and categorized as <= 3.5, >3.5-<= 4.0, >4.0-<= 4.5, >4.5-<= 5.0 (reference), >5.0-<= 5.5, >5.5-<= 6.0, and >6.0 mmol/L. Outcome: The combined outcome death before KRT or start of KRT. Analytical Approach: The association between categorical and continuous time-varying potassium and death or KRT start was examined using Cox proportional hazards and restricted cubic spline analyses, adjusted for age, sex, diabetes, cardiovascular disease, renin-angiotensin-aldosterone system (RAAS) inhibition, eGFR, and subjective global assessment (SGA). Results: At baseline, 66% of participants were men, 42% had diabetes, 47% cardiovascular disease, and 54% used RAAS inhibitors. Their mean age was 76 +/- 7 (SD) years, mean eGFR was 17 +/- 5 (SD) mL/min/1.73 m(2), and mean SGA was 6.0 +/- 1.0 (SD). Over 8 years, 414 (24%) died before starting KRT, and 595 (35%) started KRT. Adjusted hazard ratios for death or KRT according to the potassium categories were 1.6 (95% CI, 1.1-2.3), 1.4 (95% CI, 1.1-1.7), 1.1 (95% CI, 1.0-1.4), 1 (reference), 1.1 (95% CI, 0.9-1.4), 1.8 (95% CI, 1.4-2.3), and 2.2 (95% CI, 1.5-3.3). Hazard ratios were lowest at a potassium of about 4.9 mmol/L. Limitations: Shorter intervals between potassium measurements would have allowed for more precise estimations. Conclusions: We observed a U-shaped relationship between serum potassium and death or KRT start among patients with incident CKD 4- 5, with a nadir risk at a potassium level of 4.9 mmol/L. These findings underscore the potential importance of preventing both high and low potassium in patients with CKD 4-5.
引用
收藏
页码:257 / +
页数:11
相关论文
共 43 条
[1]   Prevalence of hypokalemia in older persons: results from the PolSenior national survey [J].
Adamczak, Marcin ;
Chudek, Jerzy ;
Zejda, Jan ;
Bartmanska, Magdalena ;
Grodzicki, Tomasz ;
Zdrojewski, Tomasz ;
Wiecek, Andrzej .
EUROPEAN GERIATRIC MEDICINE, 2021, 12 (05) :981-987
[2]   Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine [J].
Agarwal, Rajiv ;
Kolkhof, Peter ;
Bakris, George ;
Bauersachs, Johann ;
Haller, Hermann ;
Wada, Takashi ;
Zannad, Faiez .
EUROPEAN HEART JOURNAL, 2021, 42 (02) :152-161
[3]   Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes [J].
Bakris, George L. ;
Agarwal, Rajiv ;
Anker, Stefan D. ;
Pitt, Bertram ;
Ruilope, Luis M. ;
Rossing, Peter ;
Kolkhof, Peter ;
Nowack, Christina ;
Schloemer, Patrick ;
Joseph, Amer ;
Filippatos, Gerasimos .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2219-2229
[4]   Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes [J].
Collins, Allan J. ;
Pitt, Bertram ;
Reaven, Nancy ;
Funk, Susan ;
McGaughey, Karen ;
Wilson, Daniel ;
Bushinsky, David A. .
AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (03) :213-221
[5]   Serum Potassium and Mortality Risk in Hemodialysis Patients: A Cohort Study [J].
de Rooij, Esther N. M. ;
Dekker, Friedo W. ;
Le Cessie, Saskia ;
Hoorn, Ewout J. ;
de Fijter, Johan W. ;
Hoogeveen, Ellen K. .
KIDNEY MEDICINE, 2022, 4 (01)
[6]  
European Medicines Agency, 2022, Kerendia (finerenone). [CHMP post-authorisation summary of positive opinion for Kerendia (II- 01-G)]
[7]  
European Medicines Agency, 2016, Xigduo/Vokanamet/Synjardy/Jardiance/Invokana/ Forxiga Article-20 procedure, Annex I-III
[8]  
European Renal Association/ European Dialysis and Transplant Association, 2011, ERA-EDTA Registry Annual Report 2009
[9]   Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project [J].
Gasparini, Alessandro ;
Evans, Marie ;
Barany, Peter ;
Xu, Hairong ;
Jernberg, Tomas ;
Arnlov, Johan ;
Lund, Lars H. ;
Carrero, Juan-Jesus .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (09) :1534-1541
[10]   Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD [J].
Gritter, Martin ;
Wouda, Rosa D. ;
Yeung, Stanley M. H. ;
Wieers, Michiel L. A. ;
Geurts, Frank ;
De Ridder, Maria A. J. ;
Ramakers, Christian R. B. ;
Vogt, Liffert ;
De Borst, Martin H. ;
Rotmans, Joris I. ;
Hoorn, Ewout J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (09) :1779-1789